nih glp 1 A new study has revealed how GLP-1 medications such as semaglutide work inside brain cells, offering fresh insight into appetite control, weight loss, and why patients respond differently to these drugs The expanding scope of GLP-1

This study also demonstrated a positive correlation between treatment with GLP-1 analog and enhanced cognitive restraint scores, suggesting potential therapeutic implications for GLP-1 analogs in specified EDs management

On the manufacturer side, Benefits and Pensions Monitor , citing Reuters and The Globe and Mail , reported that Eli Lilly planned to cut the Canadian list price of a four-week supply of Mounjaro and Zepbound to $300 for the 2.5 mg and 5 mg doses and $420 for the 7.5 mg and 10 mg doses, with the new prices taking effect December 29 [Source: benefitsandpensionsmonitor.com/benefits/pharma/eli-lilly-cuts-canadian-obesity-drug-prices/392905]

Time-intensive with multiple clinic visits

It raises blood sugar and insulin levels: the extra production of oil may clog pores